Name, year | Vessel | Pathology | TP | FP | FN | TN | Sensitivity | Specificity | negative LR (95% CI) | positive LR (95% CI) |
---|---|---|---|---|---|---|---|---|---|---|
Han-Hwa Hu, 1993 [10] | oaa | 0 | 21 | 20 | 4 | 87 | 85.70% | 80.90% | 0.197 (0.080 to 0.485) | 4.49 (2.92 to 6.91) |
Jimenez-Aragon, 2013 [14] | oa | 2 | 7 | 6 | 5 | 53 | 54.60% | 90.00% | 0.464 (0.236 to 0.911) | 5.74 (2.34 to 14.06) |
Martinez, 2005 [15] | oa | 2 | 19 | 2 | 4 | 24 | 82.60% | 92.30% | 0.188 (0.077 to 0.462) | 10.74 (2.80 to 41.21) |
Suprasanna, 2014 [16] | oa | 2 | 24 | 9 | 1 | 44 | 96.00% | 83.00% | 0.048 (0.007 to 0.330) | 5.65 (3.10 to 10.31) |
Basturk, 2012 [13] | oa | 1 | 40 | 20 | 11 | 47 | 78.40% | 70.00% | 0.307 (0.178 to 0.531) | 2.63 (1.77 to 3.90) |
Paivansalo, 1999 [11] | oa | 0 | 13 | 2 | 35 | 44 | 27.00% | 96.00% | 0.762 (0.635 to 0.915) | 6.23 (1.49 to 26.10) |
Arai, 1998 [12] | oa | 1 | 14 | 8 | 11 | 19 | 56.00% | 72.00% | 0.625 (0.377 to 1.037) | 1.89 (0.96 to 3.72) |
Jimenez-Aragon, 2013 [14] | craa | 2 | 6 | 4 | 6 | 55 | 50.00% | 94.00% | 0.536 (0.303 to 0.948) | 7.38 (2.45 to 22.21) |
Arai, 1998 [12] | cra | 1 | 16 | 10 | 9 | 17 | 64.00% | 63.00% | 0.572 (0.315 to 1.039) | 1.73 (0.97 to 3.06) |
Han-Hwa Hu, 1993 [10] | cra | 0 | 21 | 11 | 4 | 96 | 84.00% | 89.60% | 0.178 (0.072 to 0.439) | 8.17 (4.55 to 14.67) |
Paivansalo, 1999 [11] | cra | 0 | 15 | 6 | 33 | 40 | 31.00% | 88.00% | 0.791 (0.634 to 0.986) | 2.4 (1.02 to 5.64) |
Arsène, 2002 [18] | cra | 3 | 48 | 11 | 21 | 22 | 70.00% | 66.00% | 0.457 (0.297 to 0.702) | 2.09 (1.26 to 3.47) |
Plange, 1999 [17] | cra | 2 | 30 | 4 | 32 | 36 | 48.40% | 90.00% | 0.573 (0.441 to 0.745) | 4.84 (1.84 to 12.70) |
Tranquart, 1999 [19] | crva | 3 | 12 | 18 | 6 | 33 | 67.00% | 65.00% | 0.515 (0.260 to 1.021) | 1.89 (1.15 to 3.10) |
Williamson, 1994 [6] | crv | 3 | 6 | 3 | 2 | 19 | 75.00% | 86.00% | 0.289 (0.086 to 0.972) | 5.5 (1.79 to 16.94) |